دورية أكاديمية

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study

التفاصيل البيبلوغرافية
العنوان: Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
المؤلفون: Rongxu Du, Jiao Ming, Jianhao Geng, Xianggao Zhu, Yangzi Zhang, Shuai Li, Zhiyan Liu, Hongzhi Wang, Zhilong Wang, Lei Tang, Xiaotian Zhang, Aiwen Wu, Zhaode Bu, Yan Yan, Zhongwu Li, Yongheng Li, Ziyu Li, Weihu Wang
المصدر: Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)
بيانات النشر: BMC, 2022.
سنة النشر: 2022
المجموعة: LCC:Medical physics. Medical radiology. Nuclear medicine
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Adenocarcinoma of the oesophagogastric junction, Neoadjuvant chemoradiotherapy, Pathologic response, Inflammation-based and nutrition-related factors, Prediction models, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Abstract Background Multimodal therapies based on surgical resection have been recommended for the treatment of adenocarcinoma of the oesophagogastric junction (AEG). We aimed to evaluate prognostic factors in AEG patients receiving neoadjuvant chemoradiotherapy and to build predictive models. Methods T3 − T4N + M0 AEG patients with resectable Siewert type II/III tumours were enrolled in this study. All patients underwent neoadjuvant chemoradiation, followed by radical surgery or systemic therapy according to clinical response. Survival analysis was performed using the Kaplan–Meier method; multivariate analysis using the Cox proportional hazards method was also conducted. The Harrell concordance index (C-index) was used to test the prognostic value of models involving prognostic factors, and consistency between actual and predicted survival rates was evaluated by calibration curves. Results From February 2009 to February 2018, 79 patients were treated with neoadjuvant chemoradiotherapy; 60 patients of them underwent radical surgery. The R0 resection rate was 98.3%, and 46.7% of patients achieved a major pathologic response (MPR), namely, a residual tumour issue less than 10%. The 5-year overall survival (OS) rate was 63%, and the 5-year progression-free survival (PFS) rate was 48%. The incidence of grade 3 complications was 21.5%, and no grade 4 complications were reported. According to the results of univariate and multivariate analyses, we included the neutrophil–lymphocyte ratio (NLR), prognostic nutrition index (PNI), eosinophilic granulocyte (EOS) and postoperative pathologic stage in nomogram analysis to establish prediction models for OS and PFS; the C-index of each model was 0.814 and 0.722, respectively. Both the C-index and calibration curves generated to validate consistency between the actual and predicted survival indicated that the models were well calibrated and of good predictive value. Conclusions AEG patients achieved favourable downstaging and pathologic response after neoadjuvant chemoradiation, with acceptable adverse effects. Inflammation-based and nutrition-related factors and postoperative pathologic stage had a significant influence on OS and PFS, and the predictive value was verified through prognostic models.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1748-717X
Relation: https://doaj.org/toc/1748-717X
DOI: 10.1186/s13014-022-02016-3
URL الوصول: https://doaj.org/article/c9f4be41423541cc89fa8c6e42f9cd60
رقم الأكسشن: edsdoj.9f4be41423541cc89fa8c6e42f9cd60
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1748717X
DOI:10.1186/s13014-022-02016-3